Laboratory：Akiruno
0 results
Selected search options |
- TOP
- pathological test
- histopathological test
- Lung cancer PD-L1 protein (IHC)22C3
Laboratory：Akiruno
○Lung cancer PD-L1 protein (IHC)22C3
CODE：06269 7
-
TEST NAME
SPECIMEN SUBMISSION
SPECIMEN
REQUIREMENT
CONTAINER CAP COLOR STORE
TEMPERATURE
(STABILITY) TURNAROUND
TIME (DAY) METHODOLOGY -
Lung cancer PD-L1 protein (IHC)22C3
Unstained specimen slide 4 pieces Z10
5-7 Immunohistochemical staining method
COMMENT
How to Submit Lung Carcinoma PD-L1 Protein (IHC) 22C3
1) Since the presence or absence of carcinoma cells may be unknown, please attach a copy of the pathology report when requesting the test. (However, this is not required if the company is conducing general pathology tests.) If for some reason you cannot attach this information, please include the name of the pathology diagnosis (tissue type, etc.) and as much clinical information, etc. as possible in the request form.
2) Materials shall be unstained specimen slides (prepared from formalin-fixed paraffin blocks) of lung carcinoma (primary or metastatic). Please use silane or other coating slides, and after thinly sectioning, dry the slides overnight at approximately 40°C before submission.
3) Thinly section the tissue to a thickness of 4-5 μm and attach on the center to the extent possible, at least 15 mm away from the frosted glass edge and 15 mm away from the glass slide edge.
4) When requesting with paraffin blocks, please contact with our sales staff as the turnaround time will be delayed due to the preparation of unstained specimen slides.
Please use silane or other coating slides, and after thinly sectioning, dry the slides overnight at approximately 40°C before submission.
3) Thinly section the tissue to a thickness of 4-5 μm and attach on the center to the extent possible, at least 15 mm away from the frosted glass edge and 15 mm away from the glass slide edge.
CONTAINER
![[オブジェクトケース] プレパラート (スライドグラス)](../../common/yoki-images/z10.jpg)
Z10 旧容器記号 t 30
[オブジェクトケース]
プレパラート (スライドグラス)
貯蔵方法：室温
supplementary information
肺癌 PD-L1タンパク (IHC) 22C3 の注意事項
TPS (Tumor Proportion Score)： 腫瘍細胞中のPD-L1発現陽性細胞の割合判定基準 TPS（％） 判定 0 陰性 1-49 発現あり 50以上 高発現 -
ペムブロリズマブの投与基準
(試薬添付文書より)対象患者 投与基準 既治療 非小細胞肺癌 TPSが1％以上 未治療 非小細胞肺癌 TPSが50％以上
